Articles written by: Tamara Wilson

Westwood Management Has Decreased Facebook  Cl A (FB) Holding By $475,600; 3D Systems (DDD) Sentiment Is 1.36

Westwood Management Has Decreased Facebook Cl A (FB) Holding By $475,600; 3D Systems (DDD) Sentiment Is 1.36

Westwood Management Corp decreased Facebook Inc. Cl A (FB) stake by 0.69% reported in 2018Q3 SEC filing. Westwood Management Corp sold 2,900 shares as Facebook Inc. Cl A (FB)’s stock declined 13.60%. The Westwood Management Corp holds 415,750 shares with $68.37 million value, down from 418,650 last quarter. Facebook Inc. […]

Lawson Products (LAWS) Holder White Pine Capital Has Cut Stake by $557,898; As Corning (GLW) Stock Value Declined, Shareholder Cypress Capital Group Has Cut Stake by $476,000

Lawson Products (LAWS) Holder White Pine Capital Has Cut Stake by $557,898; As Corning (GLW) Stock Value Declined, Shareholder Cypress Capital Group Has Cut Stake by $476,000

White Pine Capital Llc decreased its stake in Lawson Products Inc (LAWS) by 61.1% based on its latest 2018Q3 regulatory filing with the SEC. White Pine Capital Llc sold 16,906 shares as the company’s stock declined 14.53% with the market. The institutional investor held 10,764 shares of the consumer durables […]

American Intl Group Com (AIG) Shareholder Becker Capital Management Increased Its Stake by $455,800 as Stock Price Declined; Jag Capital Management Increases Stake in Lululemon Athletica  (LULU)

American Intl Group Com (AIG) Shareholder Becker Capital Management Increased Its Stake by $455,800 as Stock Price Declined; Jag Capital Management Increases Stake in Lululemon Athletica (LULU)

Becker Capital Management Inc increased its stake in American Intl Group Com (AIG) by 0.86% based on its latest 2018Q3 regulatory filing with the SEC. Becker Capital Management Inc bought 8,600 shares as the company’s stock declined 28.85% with the market. The institutional investor held 1.00M shares of the finance […]

As Cvs Health (CVS) Valuation Declined, Shareholder Joel Isaacson & Company Has Lowered Position; Parametric Portfolio Associates Maintains Position in Umpqua Holdings (UMPQ)

As Cvs Health (CVS) Valuation Declined, Shareholder Joel Isaacson & Company Has Lowered Position; Parametric Portfolio Associates Maintains Position in Umpqua Holdings (UMPQ)

Parametric Portfolio Associates Llc increased its stake in Umpqua Holdings Corp (UMPQ) by 20.56% based on its latest 2018Q3 regulatory filing with the SEC. Parametric Portfolio Associates Llc bought 178,242 shares as the company’s stock declined 18.98% with the market. The institutional investor held 1.05M shares of the savings institutions […]

As United Parcel Service Cl B (UPS) Stock Value Declined, S-R Schill & Associates Increased Position; As Starbucks (SBUX) Valuation Rose, Shareholder American Century Companies Decreased Holding

As United Parcel Service Cl B (UPS) Stock Value Declined, S-R Schill & Associates Increased Position; As Starbucks (SBUX) Valuation Rose, Shareholder American Century Companies Decreased Holding

S-R Schill & Associates increased its stake in United Parcel Service Inc Cl B (UPS) by 0.82% based on its latest 2018Q3 regulatory filing with the SEC. S-R Schill & Associates bought 2,710 shares as the company’s stock declined 16.04% with the market. The institutional investor held 332,889 shares of […]

Triple Frond Partners Has Lowered Liberty Global Plc (LBTYK) Position by $30.80 Million as Market Value Declined; Bottomline Tech Del (EPAY) Holding Held by Advisory Services Network Llc

Triple Frond Partners Has Lowered Liberty Global Plc (LBTYK) Position by $30.80 Million as Market Value Declined; Bottomline Tech Del (EPAY) Holding Held by Advisory Services Network Llc

Triple Frond Partners Llc decreased its stake in Liberty Global Plc (LBTYK) by 38.8% based on its latest 2018Q3 regulatory filing with the SEC. Triple Frond Partners Llc sold 1.10 million shares as the company’s stock declined 14.03% with the market. The institutional investor held 1.74M shares of the television […]

Comparison of Applied Genetic Technologies Corporation (AGTC) and Caladrius Biosciences Inc. (NASDAQ:CLBS).

Both Applied Genetic Technologies Corporation (NASDAQ:AGTC) and Caladrius Biosciences Inc. (NASDAQ:CLBS) are Biotechnology companies, competing one another. We will compare their institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Applied Genetic Technologies Corporation 27.91M […]

Smead Capital Management Lowered Wells Fargo Co New (WFC) Holding; Jpmorgan Chase Capital Xvi JP Morgan Alerian Mlp E (NYSEARCA:AMJ) Sellers Increased By 3.02% Their Shorts

Smead Capital Management Lowered Wells Fargo Co New (WFC) Holding; Jpmorgan Chase Capital Xvi JP Morgan Alerian Mlp E (NYSEARCA:AMJ) Sellers Increased By 3.02% Their Shorts

Smead Capital Management Inc decreased Wells Fargo Co New (WFC) stake by 2.6% reported in 2018Q3 SEC filing. Smead Capital Management Inc sold 35,701 shares as Wells Fargo Co New (WFC)’s stock declined 15.07%. The Smead Capital Management Inc holds 1.34M shares with $70.38M value, down from 1.37M last quarter. […]

As Cummins (CMI) Market Value Declined, Campbell & Company Investment Adviser Decreased Holding by $365,000; As Intuit (INTU) Market Valuation Declined, Eulav Asset Management Has Lifted Holding by $771,800

As Cummins (CMI) Market Value Declined, Campbell & Company Investment Adviser Decreased Holding by $365,000; As Intuit (INTU) Market Valuation Declined, Eulav Asset Management Has Lifted Holding by $771,800

Campbell & Company Investment Adviser Llc decreased its stake in Cummins Inc (CMI) by 62.41% based on its latest 2018Q3 regulatory filing with the SEC. Campbell & Company Investment Adviser Llc sold 2,500 shares as the company’s stock declined 4.30% with the market. The hedge fund held 1,506 shares of […]

EPS for Enanta Pharmaceuticals, Inc. (ENTA) Expected At $1.64; Jones Lang Lasalle (JLL)’s Sentiment Is 0.97

EPS for Enanta Pharmaceuticals, Inc. (ENTA) Expected At $1.64; Jones Lang Lasalle (JLL)’s Sentiment Is 0.97

Analysts expect Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) to report $1.64 EPS on February, 6.They anticipate $0.86 EPS change or 110.26% from last quarter’s $0.78 EPS. ENTA’s profit would be $31.86 million giving it 11.72 P/E if the $1.64 EPS is correct. After having $1.30 EPS previously, Enanta Pharmaceuticals, Inc.’s analysts see […]